These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11289060)

  • 1. A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure.
    Tataranni PA; Baier L; Jenkinson C; Harper I; Del Parigi A; Bogardus C
    Diabetes; 2001 Apr; 50(4):901-4. PubMed ID: 11289060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima Indians.
    Jenkinson CP; Hanson R; Cray K; Wiedrich C; Knowler WC; Bogardus C; Baier L
    Int J Obes Relat Metab Disord; 2000 Oct; 24(10):1233-8. PubMed ID: 11093282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism.
    Higuchi S; Muramatsu T; Murayama M; Hayashida M
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1199-205. PubMed ID: 7980596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians.
    Goldman D; Urbanek M; Guenther D; Robin R; Long JC
    Am J Med Genet; 1997 Jul; 74(4):386-94. PubMed ID: 9259374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse.
    Goldman D; Urbanek M; Guenther D; Robin R; Long JC
    Alcohol; 1998 Jul; 16(1):47-52. PubMed ID: 9650635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
    Itokawa M; Arinami T; Futamura N; Hamaguchi H; Toru M
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1369-75. PubMed ID: 7902708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
    Chen CH; Chien SH; Hwu HG
    Am J Med Genet; 1996 Jul; 67(4):418-20. PubMed ID: 8837714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in
    Piaggi P; Masindova I; Muller YL; Mercader J; Wiessner GB; Chen P; ; Kobes S; Hsueh WC; Mongalo M; Knowler WC; Krakoff J; Hanson RL; Bogardus C; Baier LJ
    Diabetes; 2017 Aug; 66(8):2284-2295. PubMed ID: 28476931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dopamine D2 receptor molecular variant with schizophrenia.
    Arinami T; Itokawa M; Enguchi H; Tagaya H; Yano S; Shimizu H; Hamaguchi H; Toru M
    Lancet; 1994 Mar; 343(8899):703-4. PubMed ID: 7907680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism.
    Stefan N; Vozarova B; Del Parigi A; Ossowski V; Thompson DB; Hanson RL; Ravussin E; Tataranni PA
    Int J Obes Relat Metab Disord; 2002 Dec; 26(12):1629-32. PubMed ID: 12461680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
    Itokawa M; Arinami T; Toru M
    J Pharmacol Sci; 2010; 114(1):1-5. PubMed ID: 20716857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arg64 beta3-adrenoceptor variant and the components of energy expenditure.
    Walston J; Andersen RE; Seibert M; Hilfiker H; Beamer B; Blumenthal J; Poehlman ET
    Obes Res; 2003 Apr; 11(4):509-11. PubMed ID: 12690078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity.
    Southon A; Walder K; Sanigorski AM; Zimmet P; Nicholson GC; Kotowicz MA; Collier G
    Diabetes Nutr Metab; 2003 Feb; 16(1):72-6. PubMed ID: 12848308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body weight gain in free-living Pima Indians: effect of energy intake vs expenditure.
    Tataranni PA; Harper IT; Snitker S; Del Parigi A; Vozarova B; Bunt J; Bogardus C; Ravussin E
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1578-83. PubMed ID: 12975636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia.
    Laurent C; Bodeau-Péan S; Campion D; d'Amato T; Jay M; Dollfus S; Thibault F; Petit M; Samolyk D; Martinez M
    Psychiatr Genet; 1994; 4(4):229-30. PubMed ID: 7712120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family.
    del Giudice EM; Santoro N; Cirillo G; D'Urso L; Di Toro R; Perrone L
    Diabetes; 2001 Sep; 50(9):2157-60. PubMed ID: 11522684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk.
    Verga M; Macciardi F; Pedrini S; Cohen S; Smeraldi E
    Schizophr Res; 1997 May; 25(2):117-21. PubMed ID: 9187010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Ser311Cys polymorphism in the dopamine D2 receptor gene and schizophrenia risk: a meta-analysis in Asian populations.
    Liu ZW; Liu JL; An Y; Zhang L; Wang YM
    Genet Mol Res; 2012 Feb; 11(1):261-70. PubMed ID: 22370928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome Sequencing Identifies A Nonsense Variant in DAO Associated With Reduced Energy Expenditure in American Indians.
    Piaggi P; Köroğlu Ç; Nair AK; Sutherland J; Muller YL; Kumar P; Hsueh WC; Kobes S; Shuldiner AR; Kim HI; Gosalia N; Van Hout CV; Jones M; Knowler WC; Krakoff J; Hanson RL; Bogardus C; Baier LJ
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e3989-4000. PubMed ID: 32818236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.